巴曲酶治疗突发性聋的疗效观察  

Effects of Batroxobin on Sudden Deafness

作　　者：方耀云[1] 周其友[1] 吴涛[1] 胡博华[1] 杨仕明[1] 仇春燕[1] 于黎明[1] 

机构地区：[1]中国人民解放军总医院耳鼻咽喉科研究所

出　　处：《听力学及言语疾病杂志》1997年第2期57-59,共3页Journal of Audiology and Speech Pathology

摘　　要：巴曲酶（Ｂａｔｒｏｘｏｂｉｎ）治疗突发性聋与扩管药组进行疗效对比。巴曲酶治疗有效率为７３％。其中治愈率４１％。而扩血管药治疗有效率与治愈率依次为６４％和２３％。阐述了巴曲酶主要药理作用，且介绍该药应用的适应症、禁忌证和副作用，讨论了突聋与预后的影响因素。This paper primarily discusses the effects of batroxobin on sudden idiopathic deafness and comparison is made between batroxobin and vasodilators.73% of the patients treated with batroxobin showed hearing improvement with 41% of full recovery,whereas in patients treated with vasodilators improvement rate was 61% with 23% rate of full recorvery.Primary pharmacological mechanism in dication/contra indications and side effects of Batroxobin are also discussed.Also included in the paper are analysis of factors influencing prognosis of sudden deafness.

关 键 词：巴曲酶 耳聋 突发性耳聋 药物疗法 

分 类 号：R764.437[医药卫生—耳鼻咽喉科] R977.3[医药卫生—临床医学]